The weeklong Antibody Therapeutics pipeline reveals the exciting developments in next-generation antibody therapeutics, including Antibody-Drug Conjugates, Bispecific Antibody Therapeutics, and Cancer Immunotherapies. Along with engineering breakthroughs, this pipeline also explores successful R&D strategies, translational case studies, clinical results, and efficacy data for these promising molecules.

Conferences Include:

January 8-9

Engineering Next-Generation Cancer Immunotherapies

January 9-10

Antibody-Drug Conjugates

January 11-12

Bispecific Antibody Therapeutics